Somahlution LLC provides medical products focused on ischemia reperfusion injury using patented and proprietary technologies. It offers DuraGraft, one time intraoperative vascular graft treatment that maintains endothelial function and structure. The company was founded by Vithalbhai Dhaduk and C. Satish Chandran in 2010 and is headquartered in Jupiter, FL.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Doheny Eye Institute is an American private company located in Los Angeles, CA. The firm provides eye care related research and education programs. Marissa Goldberg is currently the CEO of the company.\nThe company says this about itself: For more than 70 years, Doheny Eye Institute has been at the forefront of vision science. From seeking new ways to free blockages that prevent fluid drainage in glaucoma, to replacing retinal cells in age-related macular degeneration, to providing colleagues worldwide with standardized analyses of anatomical changes in the eyes of patients, Doheny clinician-scientists and researchers are changing how people see �� and also how they think about the future of vision. Doheny Eye Institute and UCLA Stein Eye Institute have joined forces to offer the best patient care, vision research, and education. This affiliation combines the strength, reputation, and distinction of two of the nation's top eye institutions to advance vision research, education, and patient care in California.

Xvivo Perfusion AB is a medical technology company. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. It operates through the Durable Goods and Non-Durable Goods segments. The Durable Goods segment includes sales and rental revenues from machines. The Non-Durable Goods segment covers sales of goods and services that are not durable goods. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden.

Rayner Surgical, Inc., a subsidiary of Rayner Surgical Group Ltd., is an American company located in New York, NY, that manufactures and sells surgical & optical products. It was founded in 2017. Timothy James Clover has been the CEO since 2014.

Eurocanarias Oftalmológica SL is a Spanish private company. The firm provides eye care services.

Marizyme is a development-stage company dedicated to the commercialization of therapies that address the urgent need for higher mortality and costs in the acute care space. The company's first product candidates are derived from a broad intellectual property portfolio around a novel system of proteolytic enzymes called ProteomeX (previously referred to as Krillase Technology). Marizyme completed the acquisition of these assets and intends to immediately develop several product candidates that will address unmet medical needs in the acute care setting.

Entravision, Inc., part of AbbVie, Inc., is an American company. The firm manufactures opthalmic surgery products. It was acquired by Allergan, Inc. on March 03, 1992.

Allergan Pharmaceuticals Ireland operates as a sterile pharmaceutical ophthalmic and biologics plant. It offers chemistry, microbiology laboratories and research and development support activities. The company was founded in 1977 and is headquartered in Westport, Ireland.

Retina Implant AG is the leading developer of subretinal implants for partially sighted and blind patients. After extensive research with German university hospitals and institutes which began with a large grant from the German Federal Ministry of Research and Education in 1996, Retina Implant AG was founded by Dr. Eberhart Zrenner and his colleagues in 2003 with private investors with the goal of developing the first fully-functioning electronic retinal implant to restore useful vision to the blind. Retina Implant began implanting in human patients in 2005, and has started a second clinical trial this year.

Tribos LLC develops recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age, and inflammation-related conditions. The company was founded by Edward R. Truitt, Harry Barnett, Edmund R. Pitcher and Benjamin D. Sullivan and is headquartered in Framingham, MA.

NxStage Medical, Inc. (NxStage) is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).

Xi'an Lexi Medical Technology Co., Ltd., established on 2017-02-15, Business scope includes general items:Production of protective equipment for medical personnel(Ι class medical device);Manufacturing of daily chemical products;Production of Class I Medical Devices;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Sales of Class I Medical Devices;Sales of Class II Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Sales of hygiene products and single-use medical products;Import and export;Technology Import and Export;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);software development;Internet of Things Technology Services;Supply Chain Management Services;marketing planning;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of hygiene products and single-use medical products;Production of Class II Medical Devices;Production of Class III Medical Devices;Production of protective equipment for medical personnel(Class II medical device);pharmaceutical production(Steamed Chinese Herbal Pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines);Production of disinfection products for the prevention and control of infectious diseases;Drug import and export;Drug Wholesale;Class III medical device business;Drug retail.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.